A comparison of transcriptional activation by ERα and ERβ

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 165-175

  Cowley, Shaun M ^a   Parker, Malcolm G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; POLYMERASE CHAIN REACTION; REPORTER GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; COS CELLS; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MUTATION; RECEPTORS, ESTROGEN; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS);

EID: 0032976793     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00055-2     Document Type: Conference Paper

References (42)

1. Mosselman S., Polman J., Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Letters. 392:1996;49-53.
2. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA. 93:1996;5925-5930.
3. Cowley S., Hoare S., Mosselman S., Parker M.G. ERα and ERβ form heterodimers on DNA. J. Biol. Chem. 272:1997;19,858-19,862.
4. Pettersson K., Grandien K., Kuiper G.G.J.M., Gustafsson J-A. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α Mol. End. 11:1997;1486-1496.
5. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
6. Lees J.A., Fawell S.E., Parker M.G. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:1989;5477-5488.
7. Bunone G., Briand P-A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
8. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen-receptor through phosphorylation by mitogen-activated protein-kinase. Science. 270:1995;1491-1494.
9. Ignar-Trowbridge D.M., Teng C.T., Ross K.A., Parker M.G., Korach K.S., McLachlan J.A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:1993;992-998.
10. Ignar-Trowbridge D.M., Pimentel M., Parker M.G., McLachlan J.A., Korach K.S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
11. Danielian P.S., White R., Lees J.A., Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1992;1025-1033.
12. Wurtz J-M., Bourguet W., Renaud J-P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Structural Biology. 3:1996;87-94.
13. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J-A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
14. Onate S.A., Tsai S.Y., Tsai M-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
15. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S-C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
16. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;101-108.
17. Hong H., Kohli K., Trivedi A., Johnson D.L., Stallcup M.R. Grip1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone-binding domains of steroid-receptors. Proc. Natl Acad. Sci. USA. 93:1996;4948-4952.
18. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
19. Hanstein B., Eckner R., DiRenzo J., Halachmi S., Liu H., Searcy B., Kurokawa R., Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl Acad. Sci, USA. 93:1996;11,540-11,545.
20. Yao T-P., Ku G., Zhou N., Scully R., Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl Acad. Sci. USA. 93:1996;10,626-10,631.
21. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F., Giguere V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β Molecular Endocrinology. 11:1997;353-365.
22. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 183:1997;863-870.
23. White R., Lees J.A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1:1987;735-744.
24. Cavaillès V., Dauvois S., Danielian P.S., Parker M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl Acad. Sci. USA. 91:1994;10,009-10,013.
25. Kalkhoven E., Valentine J.E., Heery D.M., Parker M.G. Isoforms of steroid receptor coactivator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17:1998;232-243.
26. Cavaillès V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:1995;3741-3751.
27. Sleigh M.J. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal. Biochem. 156:1986;251-256.
28. Tzukerman M.T., Esty A., Santisomere D., Danielian P., Parker M.G., Stein R.P.J.W., McDonnell D.P. Human estrogen-receptor transactivational capacity is determined by both cellular and promoter context and mediated by 2 functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
29. McInerney E.M., Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen-receptor required for antiestrogen-dependent and estradiol-dependent transcription activation. J. Biol. Chem. 271:1996;24,172-24,178.
30. Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
31. Imakado S., Koike S., Kondo S., Sakai M., Muramatsu M. The N-terminal transactivation domain of rat estrogen receptor is localized in a hydrophobic domain of eighty amino acids. J. Biochem. (Tokyo). 109:1991;684-689.
32. Metzger D., Ali S., Bornert J.M., Chambon P. Characterization of the amino-terminal transcriptional activation function of the human estrogen-receptor in animal and yeast-cells. J. Biol. Chem. 270:1995;9535-9542.
33. McInerney E.M., Tsai M.J., Omalley B.W., Katzenellenbogen B.S. Analysis of estrogen-receptor transcriptional enhancement by a nuclear hormone-receptor coactivator. Proc. Natl Acad. Sci. USA. 93:1996;10,069-10,073.
34. Ali S., Metzger D., Bornert J-M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
35. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. Biochem. & Biophys. Res. Commun, 236:1997;140-145.
36. Henttu P.M.A., Kalkhoven E., Parker M.G. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. & Cell. Biol. 17:1997;1832-1839.
37. Heery D.M., Parker M.G. Ligand-induced transcription by nuclear receptors. Retinoids. 13:1997;26-30.
38. Barettino D., Ruiz M.D.M.V., Stunnenberg H.G. Characterization of the ligand-dependent transactivation domain of thyroid-hormone receptor. EMBO J. 13:1994;3039-3049.
39. Durand B., Saunder M., Gaudon C., Roy B., Losson R., Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:1994;5370-5382.
40. Saatcioglu F., Bartunek P., Deng T., Zenke M., Karin M. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13:1993;3675-3685.
41. Feng W., Ribeiro R.C.J., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick R.J., Baxter J.D., Kushner P.J., West B.L. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280:1998;1747-1749.
42. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J-A., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.